Home
Diseases
Peripheral Neuropathy

Peripheral Neuropathy

Disease

Disease Profile

Peripheral neuropathy is a disorder of peripheral nerves causing numbness, pain, tingling, weakness, and autonomic dysfunction, with etiologies including diabetes, toxins, infections, and immune conditions.

Category: neurological disorder
Prevalence: Peripheral neuropathy affects an estimated 20 million people in the United States.

Related News

Multiple Myeloma Treatment Landscape Evolves with T-Cell Therapies, Trial Design Challenges

Jun 01, 2026

The treatment landscape for multiple myeloma is evolving rapidly with T-cell engaging therapies like bispecific antibodies and CAR T-cell treatments shifting care toward a chronic condition with potential treatment breaks. This evolution is creating new side effect management challenges and complicating clinical trial design as sponsors grapple with selecting comparator arms and adapting to a rapidly shifting standard of care.

FDA Approves Lifyorli Plus Nab-Paclitaxel for Platinum-Resistant Ovarian Cancer

Mar 26, 2026

The FDA has approved Lifyorli (relacorilant) plus nab-paclitaxel for platinum-resistant ovarian cancer based on trial data showing improved survival. Separately, the agency granted Breakthrough Therapy designation to Lilly's sofetabart mipitecan for the same condition, expediting development of the antibody-drug conjugate.

Enfortumab Vedotin Plus Pembrolizumab Improves Survival in Muscle-Invasive Bladder Cancer

Mar 05, 2026

Phase III KEYNOTE-B15 trial demonstrates enfortumab vedotin plus pembrolizumab significantly improves event-free survival and pathologic complete response rates compared with cisplatin-based chemotherapy in muscle-invasive bladder cancer.

FDA Approves Pembrolizumab for Platinum-Resistant Ovarian Cancer

Feb 28, 2026

The FDA approved pembrolizumab in combination with paclitaxel, with or without bevacizumab, for adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma whose tumors express PD-L1 (CPS ≥1).

Innovent Doses First Patient in Phase 3 Trial of IBI354 for HER2-Positive Breast Cancer

Feb 13, 2026

Innovent Biologics has dosed the first participant in its pivotal Phase 3 HeriCare-Breast01 study evaluating IBI354, a HER2-targeted antibody-drug conjugate, as first-line treatment for unresectable locally advanced or metastatic HER2-positive breast cancer.

FDA Approves Pembrolizumab Combinations for Platinum-Resistant Ovarian Cancer

Feb 12, 2026

The FDA approved pembrolizumab (Keytruda) and Keytruda Qlex plus paclitaxel, with or without bevacizumab, for adults with PD-L1+ platinum-resistant ovarian carcinoma based on Phase 3 trial data showing improved survival outcomes.

Related Clinical Trials

NCT ID	Title	Status	Phase
NCT07548476	Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy	NOT_YET_RECRUITING	NA
NCT07501663	Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study	RECRUITING	NA
NCT07475065	The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy	NOT_YET_RECRUITING	PHASE2/PHASE3
NCT07362147	Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life	NOT_YET_RECRUITING	NA
NCT07336381	Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy	NOT_YET_RECRUITING	NA
NCT07321236	Effect of Hands and Feet Exercises on Taxane Based Chemotherapy Induced Peripheral Neuropathy in Patients With Solid Tumors	NOT_YET_RECRUITING	NA
NCT07301892	Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis	RECRUITING
NCT07301177	DoD AtMS for Posttraumatic Peripheral Neuropathic Pain	RECRUITING	NA
NCT07236515	Randomized, Sham-Controlled Investigation of the Leia Sensory Prosthesis in Individuals With Peripheral Neuropathy	NOT_YET_RECRUITING	NA
NCT07172763	The Pressure Relieving Capacity of Siliconepads Compared to Felted Foam to Relieve Caput Metatarsal 2 in a Population With Diabetes	NOT_YET_RECRUITING